In July, the Cancer History Project is highlighting the founders of cancer centers and cancer organizations, including John Ultmann, founding director of University of Chicago Cancer Research Center, now University of Chicago Medicine Comprehensive Cancer Center—and the first subscriber to The Cancer Letter.
Following the Supreme Court’s June 24 ruling on Dobbs v. Jackson Women’s Health, the Cancer History Project has created a timeline of the regulatory history of women’s reproductive rights based on news stories from The Cancer Letter that track the impact of “pro-life” policies on cancer research and cancer care.
In July, the Cancer History Project will be highlighting the founding—and founders—of oncology’s institutions. Duke Cancer Institute became an NCI-designated cancer center in 1973, two years after the signing of the National Cancer Act of 1971.
The Cancer History Project is highlighting survivor stories throughout the month of June, which we jumpstarted with interviews conducted by guest editor Deborah Doroshow, assistant professor of medicine at Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai.
Soon after Dave Boule was diagnosed with polycythemia vera in 2006, he had a hunch that there were better treatment options out there.
At 25, Elizabeth Carner was diagnosed with stage 4 colon cancer.
Since its first annual meeting in 1964, the American Society of Clinical Oncology has outgrown most U.S. convention centers—and has fostered the growth and development of generations of oncologists.
This June, the Cancer History Project will be focusing on the stories of survivors. Today, we are highlighting a 1991 excerpt from the National Coalition for Cancer Survivorship’s quarterly publication, the NCCS Networker, with commentary by Lovell Jones, a researcher whose work focuses on health disparities.
“Jim Allison: Breakthrough,” a documentary released in 2019, tells the story of 2018 Nobel Prize winner Jim Allison’s quest to cure cancer and the development of ipilimumab.
The Cancer History Project is focusing on health equity and the evolution of ethics in clinical trial research during the month of May.
